Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 11-2013 | 11-2012 | 11-2011 | 11-2010 | |
| Sales | 0 | 814,318 | 1,158,898 | 1,448,476 | 1,601,883 |
| Cost of Goods | N/A | 643,237 | 963,062 | 1,226,404 | 1,322,115 |
| Gross Profit | N/A | 171,081 | 195,836 | 222,072 | 279,768 |
| Operating Expenses | 0 | 173,533 | 179,435 | 191,495 | 156,491 |
| Operating Income | N/A | -2,215 | 16,463 | 30,981 | 123,392 |
| Interest Expense | 0 | 1 | 2 | 5 | 41 |
| Other Income | 0 | 258 | 801 | 397 | 86 |
| Pre-tax Income | 0 | -1,958 | 17,262 | 31,373 | 123,437 |
| Income Tax | N/A | 19,253 | -398 | 3,076 | -15,991 |
| Net Income Continuous | N/A | -21,211 | 17,660 | 28,297 | 139,428 |
| Net Income | $N/A | $-21,211 | $17,660 | $28,297 | $139,428 |
| EPS Basic Total Ops | N/A | -0.77 | 0.64 | 0.96 | 4.63 |
| EPS Basic Continuous Ops | N/A | -0.77 | 0.64 | 0.96 | 4.63 |
| EPS Diluted Total Ops | N/A | -0.77 | 0.63 | 0.92 | 4.46 |
| EPS Diluted Continuous Ops | N/A | -0.77 | 0.63 | 0.92 | 4.46 |
| EBITDA(a) | $N/A | $15,602 | $37,553 | $56,792 | $145,497 |